We found that Tctex1 was a significant predictor of poor overall survival (HR = 1.67, 95% CI = 1.08–2.58, p = 0.021) but not of progression-free survival (HR = 1.54, 95% CI = 0.83–2.86, p = 0.167) in GBM patients (Figure 2E). The gene discussed is DYNLT1; the disease is glioblastoma.